🇺🇸 FDA
Patent

US 11013704

Compounds supports hematopoietic stem cells and red blood cells

granted A61KA61K31/155A61K31/194

Quick answer

US patent 11013704 (Compounds supports hematopoietic stem cells and red blood cells) held by The Board of Regents of the University of Texas System expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/155, A61K31/194, A61K31/197, A61K31/20